Imagine a world where studying cancer in space could help unlock new treatments on Earth. The Cancer in LEO-3 experiment aboard Axiom Mission 4 (Ax-4) investigated triple-negative breast cancer organoids to understand how microgravity affects tumor…
The 15th annual DPHARM: Disruptive Innovations to Modernize Clinical Research (September 16–17, 2025, Philadelphia, PA) brought together senior clinical operations executives, patient advocates, and technology leaders to explore the future of clinical trials. AI, patient-centric trial…
What happens to the human body when gravity disappears? Astronauts experience rapid cardiovascular and vestibular adaptation, which can cause dizziness, fainting, or impaired performance. The Ax-4 mission’s Telemetric Health AI (TESH) study captures these physiological changes…
If we can protect an astronaut’s body in space, how do we safeguard their mind? Space health research is no longer limited to monitoring heart rates or muscle loss. On missions like Axiom-4, astronauts face one…
When astronauts are 400 km above Earth, floating in the microgravity environment of the International Space Station, even everyday tasks like looking at a screen become more complex than they are on Earth. The Ax-4 mission,…
Long-duration space travel comes with unique health challenges, and one of the most significant is muscle loss. Astronauts in microgravity environments rapidly lose muscle mass, and their muscle cells’ ability to regenerate declines. To counter this,…
What if astronauts could control machines with just their thoughts? As space travel becomes more commercial and frequent, so does the need to understand how the human brain functions in microgravity. One promising frontier in space…
